Advisor, Analytical Chemistry

LillyIndianapolis, IN
$126,000 - $204,600Onsite

About The Position

At Lilly, we serve an extraordinary purpose — we make a difference for people around the globe by discovering, developing, and delivering medicines that help them live longer, healthier, more active lives. The Radiopharmaceuticals (RLT) Chemistry, Manufacturing & Controls (CM&C) group is at the forefront of advancing therapeutic radiopharmaceuticals from clinical development through commercial launch. The Advisor, Analytical Chemist is a critical technical role within the RLT CM&C Technical Operations function. Reporting to the Senior Director, Technical Operations, this position leads the technical transfer, development, optimization, and validation of analytical methods to support phase 1b to phase 3 radiopharmaceutical programs. The Advisor serves as the primary analytical chemistry subject matter expert (SME), driving scientifically sound, phase-appropriate method strategies that meet GMP, ICH, USP, and regulatory expectations. This role operates at the intersection of analytical science, regulatory compliance, and cross-functional program delivery — collaborating closely with QC, CMC Regulatory, manufacturing, and external CDMO partners to ensure analytical readiness for late-phase development milestones and regulatory submissions.

Requirements

  • Earned Bachelor's degree in chemistry, analytical chemistry, or organic chemistry
  • 10+ years of relevant experience in analytical development, validation, and/or testing in a GMP setting.
  • Demonstrated expertise in the development and full ICH Q2(R2)-compliant validation of chromatographic (HPLC, UPLC, GC, TLC) and spectroscopic (MS, UV/Vis, gamma) analytical methods.
  • Functional knowledge of GMP regulations and applicable FDA, EMA, ICH, USP, and PDA guidelines relevant to analytical testing.
  • Proven ability to operate effectively in a cross-functional environment with strong project management and organizational skills.
  • Proficiency in analytical data systems and laboratory informatics (e.g., Empower, Chromeleon, MassLynx).
  • Strong oral and written communication skills, with demonstrated ability to present technical data to diverse audiences including senior leadership and regulatory agencies.

Nice To Haves

  • Master's degree in chemistry field with 5+ years of relevant experience, OR PhD in chemistry field with 2+ years of relevant experience
  • Experience working hands-on within the biotech or pharmaceutical industry
  • Experience with radiopharmaceutical analytical testing, including HPLC with radiometric detection, TLC (radiometric), and gamma spectroscopy for PET (F-18) and/or theranostic radioisotopes (Lu-177, Ac-225).
  • Hands-on experience authoring CMC regulatory submissions and method validation packages for late-phase (Phase 3) or commercial programs.
  • Experience with CDMO/external partner analytical qualification and method transfer in a GMP context.
  • Familiarity with regulatory expectations for late-phase radiopharmaceutical analytical control strategies (ICH Q14, Q8/Q9/Q10 pharmaceutical quality system principles).

Responsibilities

  • Lead the design, development, and optimization of analytical methods for radiopharmaceutical API and drug products, including small molecules, peptides, and radiolabeled compounds.
  • Develop and optimize chromatographic methods (HPLC, UPLC, TLC, GC) and spectroscopic methods (gamma spectroscopy, mass spectrometry, UV/Vis, NMR) as appropriate for late-phase programs.
  • Apply phase-appropriate development strategies aligned with ICH Q14, ICH Q2(R2), and applicable USP/EP compendial requirements for late clinical phase through commercial programs.
  • Identify and implement analytical technology improvements and method modernization initiatives to support continuous improvement and commercial readiness.
  • Troubleshoot complex analytical method performance issues and implement robust, validated solutions.
  • Author method validation protocols and reports in full compliance with ICH Q2(R2), USP <1225>, and applicable regulatory guidance for late-phase and commercial programs.
  • Lead analytical method qualification and validation activities at internal sites and external CDMOs/partners.
  • Perform or oversee technology transfer of validated methods to QC release and stability testing laboratories.
  • Prepare and review method transfer protocols, comparability studies, and qualification/validation reports.
  • Ensure validation data packages are complete, defensible, and ready for regulatory submission.
  • Author analytical sections of CMC regulatory submissions (INDs, CTAs, NDA/BLA, MAA), including method descriptions, validation summaries, and specification justifications.
  • Develop and justify release and stability specifications for starting materials, intermediates, and drug products in collaboration with CMC Regulatory and QA.
  • Prepare responses to regulatory agency inquiries related to analytical methods and specifications.
  • Author and review standard test methods, SOPs, change controls, and technical reports in accordance with GMP and Good Documentation Practices.
  • Support internal and external GMP audits, providing technical analytical expertise as required.
  • Ensure all analytical activities are conducted in compliance with cGMP, cGLP, applicable FDA, EMA, Health Canada, ICH, USP, PDA, and Lilly quality standards.
  • Review and approve experimental data from internal labs and external CDMOs/vendors; interpret results and document conclusions accurately.
  • Lead or support investigations of out-of-specification (OOS) results, analytical deviations, and aberrant data using robust root cause analysis methodology.
  • Serve as the analytical chemistry SME for late-phase RLT programs, providing technical direction to cross-functional CMC teams.
  • Build and maintain productive working relationships with internal, external CDMOs, analytical service providers, and regulatory partners.
  • Collaborate with QC, CMC Regulatory, Manufacturing Sciences, and Supply Chain to ensure seamless analytical readiness for clinical and commercial supply.
  • Represent analytical capabilities in project team meetings, technical reviews, and governance forums.

Benefits

  • company bonus (depending, in part, on company and individual performance)
  • company-sponsored 401(k)
  • pension
  • vacation benefits
  • medical, dental, vision and prescription drug benefits
  • flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
  • life insurance and death benefits
  • certain time off and leave of absence benefits
  • well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service